Challenges and future possibilities of using tiny drug carriers for treating aggressive brain tumors

Current standard treatment for glioblastoma includes surgery followed by radiotherapy with chemotherapy, but survival rates remain notably low.

• Glioblastoma is one of the most aggressive and deadly central nervous system tumors.
• There are significant challenges in developing effective treatment strategies for glioblastoma.
• Conventional chemotherapy methods face limitations in delivering drugs effectively to glioblastoma cells.
• Nanomedicine strategies are being explored as potentially promising alternatives for treating glioblastoma.
• There is a growing focus on the clinical translation of nanochemotherapy for glioblastoma.

Simplified